These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26711929)

  • 21. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
    Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-27a is highly expressed in H1650 cancer stem cells and regulates proliferation, migration, and invasion.
    Luo W; Zhang D; Ma S; Wang C; Zhang Q; Wang H; He K; Liu Z
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1004-S1011. PubMed ID: 30539837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
    Wei C; Zhang R; Cai Q; Gao X; Tong F; Dong J; Hu Y; Wu G; Dong X
    Aging (Albany NY); 2019 Sep; 11(17):6734-6761. PubMed ID: 31498117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-212 suppresses nonsmall lung cancer invasion and migration by regulating ubiquitin-specific protease-9.
    Chen W; Huang Y; Zhang S; Zheng X; Xie S; Mao J; Cai Y; Lu X; Hu L; Shen J; Dong Y; Chai K
    J Cell Biochem; 2019 Apr; 120(4):6482-6489. PubMed ID: 30335901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer.
    Li J; Yu T; Cao J; Liu L; Liu Y; Kong HW; Zhu MX; Lin HC; Chu DD; Yao M; Yan MX
    Cell Physiol Biochem; 2015; 37(5):1847-56. PubMed ID: 26584284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
    Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
    Ye MF; Zhang JG; Guo TX; Pan XJ
    Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 30. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
    Kumarswamy R; Mudduluru G; Ceppi P; Muppala S; Kozlowski M; Niklinski J; Papotti M; Allgayer H
    Int J Cancer; 2012 May; 130(9):2044-53. PubMed ID: 21633953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-507 represses the malignant behaviors of non-small cell lung cancer via targeting zinc finger E-box binding homeobox 2.
    Lv HL; Li ZL; Song YB
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9955-9964. PubMed ID: 31799665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
    Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
    Bai Q; Li L; Chen F; Zhu J; Cao L; Yang Y; Zhong F
    Med Sci Monit; 2020 Jun; 26():e921200. PubMed ID: 32508344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells.
    Chandimali N; Huynh DL; Zhang JJ; Lee JC; Yu DY; Jeong DK; Kwon T
    Cancer Gene Ther; 2019 Sep; 26(9-10):292-304. PubMed ID: 30341415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
    Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
    Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.